Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.4M Buy
1,174,517
+736,046
+168% +$16.3M 0.76% 61
2026
Q1
$6.41M Buy
438,471
+438,370
+434,030% +$6.43M 0.2% 113
2025
Q4
$1.28K Sell
101
-216,594
-100% -$3.19M ﹤0.01% 246
2025
Q3
$3.33M Sell
216,695
-514,905
-70% -$8.3M 0.11% 125
2025
Q2
$11.5M Sell
731,600
-123,386
-14% -$1.87M 0.42% 93
2025
Q1
$16.3M Buy
854,986
+2,493
+0.3% +$54.5K 0.74% 54
2024
Q4
$20.3M Buy
852,493
+52
+0% +$1.45K 0.79% 51
2024
Q3
$23.9M Buy
852,441
+409,055
+92% +$11.6M 0.92% 42
2024
Q2
$11.6M Buy
443,386
+1,775
+0.4% +$36.9K 0.49% 76
2024
Q1
$9.66M Buy
441,611
+5,300
+1% +$114K 0.39% 97
2023
Q4
$10.1M Buy
436,311
+116,594
+36% +$2.35M 0.43% 95
2023
Q3
$6.31M Buy
319,717
+103,775
+48% +$2.04M 0.31% 105
2023
Q2
$4.9M Buy
+215,942
New +$4.35M 0.21% 112

Other funds holding RXO

Emerald Advisers's RXO Position: Q2 2026 in Review

Emerald Advisers increased its RXO (RXO) stake by 168% in Q2 2026, buying an estimated $16.3M and bringing the position to 1,174,517 shares worth $32.4M. The position accounts for 0.76% of the portfolio, ranked #61.

Emerald Advisers first reported a position in RXO in Q2 2023 and has held it in 13 quarters since. 303 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • Emerald Advisers held 1,174,517 shares of RXO worth $32.4M as of Q2 2026.
  • Emerald Advisers bought 736,046 RXO shares in Q2 2026, an estimated $16.3M.
  • RXO made up 0.76% of Emerald Advisers's portfolio in Q2 2026, its #61 holding.
  • Emerald Advisers first reported a position in RXO in Q2 2023 and has held it in 13 quarters since.
  • 303 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on Emerald Advisers's 13F filing for Q2 2026, filed 5 Aug 2026.